This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Aventis Pharma S.a.. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Caty Casas Louzao: Innovator in Alzheimer's Research
Introduction
Caty Casas Louzao is a prominent inventor based in Barcelona, Spain. She has made significant contributions to the field of biomedical research, particularly in the study of Alzheimer's disease. Her innovative work has led to the development of transgenic animals that exhibit major disorders related to this debilitating condition.
Latest Patents
Caty Casas Louzao holds a patent for "Transgenic animals exhibiting major disorders related to Alzheimer's disease." This invention relates to nonhuman transgenic animals that can be utilized for demonstrating compounds intended for the treatment of Alzheimer's disease. The patent highlights her commitment to advancing research in this critical area.
Career Highlights
Throughout her career, Louzao has worked with notable organizations, including Aventis Pharma S.A. and Universitat Autònoma de Barcelona. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Caty has collaborated with esteemed colleagues such as Véronique Blanchard-Bregeon and Jean-Michel Itier. These partnerships have further enriched her research and expanded the impact of her work in the scientific community.
Conclusion
Caty Casas Louzao is a trailblazer in Alzheimer's research, with her innovative patent and collaborations paving the way for future advancements in treatment. Her contributions are vital in the ongoing fight against this disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile